CSIMarket


Amgen Inc   (AMGN)
Other Ticker:  
 

Amgen Inc

AMGN's Fundamental analysis








Looking into Amgen Inc growth rates, revenue grew by 21.98 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 490

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -0.98 %

Amgen Inc faced net loss in contrast to the net income a year ago in I. Quarter 2024

More on AMGN's Growth


Amgen Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Amgen Inc realized cash outflow of $ -40.77per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
43.69
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.55.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.56.


More on AMGN's Valuation
 
 Total Debt (Millions $) 64,020
 Dividend TTM ($) 8.61 $
 Dividend Yield TTM (%) 2.95 %
 Revenue/Employee (TTM) $ 1,220,331
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.54
 Tangible Book Value (Per Share $) -83.81

Amgen Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Amgen Inc realized cash outflow of $ -40.77per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
43.69
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.55.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.56.

Amgen Inc Price to Book Ratio is at 32.66 lower than Indusry Avg. of 742.47. and higher than S&P 500 Avg. of 0.01

More on AMGN's Valuation

  Market Capitalization (Millions $) 164,011
  Shares Outstanding (Millions) 536
  Employees 24,200
  Revenues (TTM) (Millions $) 29,532
  Net Income (TTM) (Millions $) 3,763
  Cash Flow (TTM) (Millions $) -21,852
  Capital Exp. (TTM) (Millions $) -998
  Total Debt (Millions $) 64,020
  Dividend TTM ($) 8.61 $
  Dividend Yield TTM (%) 2.95 %
  Revenue/Employee (TTM) $ 1,220,331
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 4.54
  Tangible Book Value (Per Share $) -83.81

  Market Capitalization (Millions $) 164,011
  Shares Outstanding (Millions) 536
  Employees 24,200
  Revenues (TTM) (Millions $) 29,532
  Net Income (TTM) (Millions $) 3,763
  Cash Flow (TTM) (Millions $) -21,852
  Capital Exp. (TTM) (Millions $) -998


    AMGN's Profitability Comparisons
Amgen Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2024 to 13.31 % from 15.51 % in IV. Quarter.




Profitability by Segment



  Ratio
   Capital Ratio (MRQ) 1.42
  Total Debt to Equity (MRQ) 12.75
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.32
  Inventory Turnover Ratio (TTM) 1.41



Amgen Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2024 to 13.31 % from 15.51 % in IV. Quarter.



More on AMGN's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com